We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanotube Carbon Fibers Can Rewire Damaged Hearts

By HospiMedica International staff writers
Posted on 05 Sep 2019
A new study shows that carbon nanotube fibers (CNTfs) can restore electrical conduction in the diseased myocardium, offering a potential long-term restorative solution.

Researchers at the Texas Heart Institute (THI; Houston, TX, USA), Rice University (Rice, Houston, TX, USA), and other institutions conducted open chest electrophysiology studies to examine the characteristics of CNTfs, which combine the mechanical properties of surgical suture materials and the conductive properties of metals, and their suitability as a restorative solution to impaired myocardial conduction. More...
To do so, the researchers first used radiofrequency (RF) ablation to create an epicardial conduction delay. They then sutured CNTf sutures over the conduction block.

The results revealed that in large animals (sheep), an improvement in conduction velocity using CNTf was demonstrated. In an acute rodent model, in which the CNTfs were surgically sewn across the right atrioventricular junction, ventricular pre-excitation was shown during sinus rhythm. All chronic cases demonstrated resumption of atrioventricular conduction, but these required atrial pacing. There was no gross or histopathologic evidence of toxicity. Ex-vivo electrical analysis of the CNTf-myocardial interface demonstrated contact impedance significantly lower than that of platinum iridium. The study was published on August 12, 2019, in Circulation: Arrhythmia and Electrophysiology.

“Instead of shocking and defibrillating, we are actually correcting diseased conduction of the largest major pumping chamber of the heart by creating a bridge to bypass and conduct over a scarred area of a damaged heart,” said co-lead author cardiologist Mehdi Razavi, MD, of THI. “Our experiments provided the first scientific support for using a synthetic material-based treatment rather than a drug to treat the leading cause of sudden death in the United States and many developing countries around the world.”

“Flexibility is important, because the heart is continuously pulsating and moving, so anything that’s attached to the heart’s surface is going to be deformed and flexed. Good interfacial contact is also critical to pick up and deliver the electrical signal,” said co-lead author chemical and biomolecular engineer Matteo Pasquali, PhD, of Rice. “In the past, multiple materials had to be combined to attain both electrical conductivity and effective contacts. These fibers have both properties built in by design, which greatly simplifies device construction and lowers risks of long-term failure due to delamination of multiple layers or coatings.”

CNTfs are about a quarter of the thickness of a human hair, but still contain millions of microscopic nanotubes of pure carbon. The fibers, which are soft, flexible, and tough, also exhibit low electrical impedance. As such, they show potential for many applications, including helping Parkinson's disease (PD) patients who require brain implants to treat their neurological conditions.

Related Links:
Texas Heart Institute
Rice University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.